TABLE 5.
Characteristics of adult patients who died from complications of COVID-19 and whose tissues were used for histologic analysis.
| Age: 61 (46–73.5) | |
| Feature | Number (%) |
| Male | 9 (69.2) |
| Race | |
| Black or African American | 4 (30.7) |
| Multiple/Other | 1 (7.7) |
| White | 7 (53.8) |
| Other | 1 (7.7) |
| ICU admission | 11 (84.6) |
| Lung histopathology | |
| COLD | 1 (7.7) |
| AB | 6 (46.1) |
| AE | 1 (7.7) |
| DAD | 2 (15.3) |
| DAD-AP | 2 (15.3) |
| DAD-EP | 2 (15.3) |
| DAD-OP | 3 (23) |
| DAD-OFP | 1 (7.7) |
| DAD-PFP | 1 (7.7) |
| Hemorrhage | 1 (7.7) |
| HT | 1 (7.7) |
| NLI | 1 (7.7) |
| PE | 1 (7.7) |
| Evidence of Bacterial CoInfection | 7 (53.8) |
| Median (IQR) | |
| BMI | 29.1 (14.9) |
| Duration of Illness (d) | 14 (71.5) |
Tissue samples cohort (n=13)
ICU: intensive care unit; BMI: body mass index; COLD: Chronic Obstructive Lung Disease; AE: Alveolar Edema; DAD: Diffuse Alveolar Damage; DAD-AP: Diffuse Alveolar Damage- Acute Phase; DAD-EP: Diffuse Alveolar Damage- Exudative Phase; DAD-OP: Diffuse Alveolar Damage- Organizing Phase; DAD-OFP: Diffuse Alveolar Damage- Organizing to Fibrotic Phase; DAD-PFP: Diffuse Alveolar Damage- Proliferative and Fibrosing Phase; HT: Herpetic Tracheobronchitis: NLI: Neutrophilic and Lymphocytic Infiltrates; PE: Pulmonary Edema; IQR:interquartile range.